Press Releases ImmuCell Corporation

Equities

ICCC

US4525253062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-11 pm EDT			5-day change	1st Jan Change
4.22 ^USD	+0.72%		-1.40%	-17.09%

Jul. 09	ImmuCell Corporation Provides Preliminary Unaudited Sales Results for the Second Quarter, Six Months and Twelve Months Ended June 30, 2024	CI
Jul. 02	Top Premarket Decliners	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024	Jul. 09	AQ
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®	Jun. 05	AQ
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders	Jun. 04	AQ
ImmuCell : May 2024 Corporate Presentation	May. 14	PU
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024	May. 14	AQ
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024	May. 08	AQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024	Apr. 09	AQ
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	Feb. 27	AQ
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	Feb. 16	AQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023	Jan. 08	AQ
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023	Nov. 13	AQ
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023	Nov. 07	AQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023	23-10-05	AQ
ImmuCell Announces Submission of CMC Technical Section to the FDA	23-08-29	AQ
ImmuCell : August 2023 Corporate Presentation	23-08-10	PU
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023	23-08-10	AQ
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023	23-08-07	AQ
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023	23-07-11	AQ
ImmuCell Announces Change in Timing of Anticipated FDA Submission	23-06-28	AQ
IMMUCELL CORP /DE/ : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ImmuCell Corporation

Equities

ICCC

US4525253062

Press Releases

Filters